<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The contribution of metabotropic <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> receptors to brain injury after in vivo <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> remains to be determined </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the effects of the metabotropic <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> receptor 1 (mGluR1) <z:chebi fb="68" ids="48706">antagonist</z:chebi> LY367385 on brain injury after transient (90 min) middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in the rat and sought to explore their mechanisms </plain></SENT>
<SENT sid="2" pm="."><plain>The intravenous administration of LY367385 (10 mg/kg) reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume at 24 h after the start of reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>As the Gq-coupled mGluR1 receptor is known to activate the PKC/Src family kinase cascade, we focused on changes in the activation and amount of these kinases </plain></SENT>
<SENT sid="4" pm="."><plain>Transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> increased the amount of activated tyrosine kinase Src and PKC in the post-synaptic density (PSD) at 4 h of reperfusion </plain></SENT>
<SENT sid="5" pm="."><plain>The administration of LY367385 attenuated the increases in the amounts of PSD-associated PKCgamma and Src after transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>We further investigated phosphorylation of the <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor, which is a major target of Src family kinases to modulate the function of the receptor </plain></SENT>
<SENT sid="7" pm="."><plain>Transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> increased the tyrosine phosphorylation of <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor subunits NR2A and NR2B </plain></SENT>
<SENT sid="8" pm="."><plain>Tyrosine phosphorylation of NR2A, but not that of NR2B, in the PSD at 4 h of reperfusion was inhibited by LY367385 </plain></SENT>
<SENT sid="9" pm="."><plain>These results suggest that the mGluR1 after transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> is involved in the activation of Src, which may be linked to the modification of properties of the <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor and the development of <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
</text></document>